Lipoprotein(a) and ageing

Clinical Laboratory

Volumn 56, Issue 9-10, 2010, Pages 463-466

  Lippi, Giuseppe ^a   Targher, Giovanni ^b   Salvagno, Gian Luca ^b   Montagnana, Martina ^b   Franchini, Massimo ^a   Guidi, Gian Cesare ^b  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Aging; Cholesterol; Lipids; Lipoprotein(a); Lipoproteins

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CARDIOVASCULAR DISEASE; MIDDLE AGED; RISK FACTOR; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CHILD; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; SEX CHARACTERISTICS;

EID: 79952112742     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Lippi G, Guidi GC. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 2003;40:1-42. (Pubitemid 36250229)
2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003;169:203-14. (Pubitemid 37297466)
3. Marcovina SM, Koschinsky ML. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 2003;14:361-6. (Pubitemid 36951901)
4. Berg K, Ro OC. Lp(a) lipoprotein level and longevity. Ann Genet 1991;34:264-9.
5. Thillet J, Doucet C, Chapman J, Herbeth B, Cohen D, FaureDelanef L. Elevated lipoprotein(a) levels and small apo(a) isoforms are compatible with longevity: evidence from a large population of French centenarians. Atherosclerosis 1998;136:389-94.
6. Pepe G, Di Perna V, Resta F, et al. In search of a biological pattern for human longevity: impact of apo A-IV genetic polymorphisms on lipoproteins and the hyper-Lp(a) in centenarians. Atherosclerosis 1998;137:407-17.
7. Malaguarnera M, Giugno I, Ruello P, et al. Lipid profile variations in a group of healthy elderly and centenarians. Eur Rev Med Pharmacol Sci 1998;2:75-9. (Pubitemid 29173977)
8. Baggio G, Donazzan S, Monti D, et al. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors. FASEB J 1998;12:433-7. (Pubitemid 28146522)
9. Arai Y, Hirose N, Nakazawa S, et al. Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status. J Am Geriatr Soc 2001;49:1434-41. (Pubitemid 33051392)
10. Kervinen K, Savolainen MJ, Salokannel J, et al. Apolipoprotein E and B polymorphisms - Longevity factors assessed in nonagenarians. Atherosclerosis 1994;105:89-95. (Pubitemid 24047751)
11. Heinimann K, Stähelin HB, Perrig-Chiello P, et al. Lipoprotein(a) and plasma lipids in 429 elderly and very old subjects: significance as risk factor, effect of nutrition and life style. Schweiz Med Wochenschr 1996;126:1487.
12. Zuliani G, Bader G, Imbastaro T, et al. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin. Aging (Milano) 1995;7:385-91.
13. Bader G, Zuliani G, Kostner GM, Fellin R. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians. Gerontology 1998; 44:293-9. (Pubitemid 28403392)
14. Matsubara M, Akita H, Shibuya H, Chiba H. Decreased longevity in Japanese men, associated with low-molecular-weight apolipoprotein(a) phenotypes. Ann Clin Biochem 2001;38:120-3. (Pubitemid 32221725)
15. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 1999;100:1481-92. (Pubitemid 29451714)
16. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502.
18. Dobiasova M. Atherogenic index of plasma [log(triglycerides/HDL- cholesterol)]: theoretical and practical implications. Clin Chem 2004;50:1113-5. (Pubitemid 38824219)
19. Lippi G, Franchini M, Salvagno GL, Guidi GC. Lipoprotein[a] and cancer: Anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev 2007;33:427-36. (Pubitemid 47336865)